FdaApplication
ANDA 212266
Identifiers
- fda_app_no: ANDA212266
Properties
| Property | Value |
|---|---|
| applicant_name | QUAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2019-05-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | CETIRIZINE HYDROCHLORIDE | 5MG/5ML | SOLUTION;ORAL |
1 product